文献速递运动医学关节外科

单字母数字评估在肩部患者中的效度和反应性

Validity and Responsiveness of the Single Alpha-numeric Evaluation for Shoulder Patients.
PubMed 文献 · Am J Sports Med · 2018-11-12

该队列研究纳入212例接受肩袖修复、全肩置换或物理治疗的肩部疾病患者,在基线和3个月随访时填写SANE和ASES量表,评估SANE的组内相关系数、测量标准误、反应性及最小临床重要差异(MCID)。结果显示SANE与ASES各组ICC2,1为0.72~0.85,SANE的MCID为15%,与ASES的11%相近,提示SANE是评估肩部疾病治疗效果的简便有效工具。

要点

  • SANE治疗前信度ICC2,1=0.84,SEM=3.8,与ASES(ICC2,1=0.82,SEM=3.4)相似。
  • SANE与ASES在肩袖修复组ICC2,1=0.85,全肩置换组0.72,物理治疗组0.82。
  • SANE的MCID为15%,曲线下面积0.79(SE 0.62,P<.001),敏感度85%。

核心结论

  • SANE对多种常见肩部诊断在手术和非手术治疗中评估患者结局均有效。
  • SANE的MCID为15%,与ASES的11%相似,提示SANE是评估肩部疾病治疗效果的简便高效工具。
  • 作者认为需进一步研究以确认这些结果并比较其他身体部位和诊断。

研究设计与样本

  • 队列研究(诊断),证据等级2。
  • 纳入接受肩袖修复(n=77)、全肩置换(n=55)或物理治疗(n=80)的患者,其中肩峰下撞击综合征61例、粘连性肩关节囊炎19例(N=212,平均年龄52.6±1.2岁,女性145例)。
  • 在基线和初始治疗或手术后3个月随访时填写SANE和ASES量表。
  • 采用组内相关系数(ICC2,1)和测量标准误(SEM)评估重测信度及SANE与ASES的效度,方差分析评估治疗反应性,受试者工作特征曲线确定MCID(α=.05),并评估地板和天花板效应。

主要发现

  • SANE治疗前信度良好(ICC2,1=0.84,SEM=3.8),与ASES(ICC2,1=0.82,SEM=3.4)相似。
  • SANE与ASES在治疗前后各治疗组中一致性良好:肩袖修复组ICC2,1=0.85,SEM=3.4;全肩置换组ICC2,1=0.72,SEM=5.2;物理治疗组ICC2,1=0.82,SEM=2.9。
  • SANE和ASES治疗后反应性相似,各治疗组内平均变化和标准差相近。
  • 受试者工作特征曲线显示曲线下面积0.79(SE 0.62,P<.001),SANE cutoff为15%,敏感度85%以确定MCID。
  • ASES和SANE的地板与天花板效应分别为4%和9%,可接受且相似。

关键数值与推荐

  • SANE的MCID为15%,ASES的MCID为11%。
  • SANE治疗前ICC2,1=0.84,SEM=3.8;ASES治疗前ICC2,1=0.82,SEM=3.4。
  • SANE与ASES在肩袖修复组ICC2,1=0.85,SEM=3.4;全肩置换组ICC2,1=0.72,SEM=5.2;物理治疗组ICC2,1=0.82,SEM=2.9。
  • 受试者工作特征曲线下面积0.79(SE 0.62,P<.001),SANE cutoff 15%时敏感度85%。
  • 地板和天花板效应:ASES 4%,SANE 9%。

临床怎么用

  • 作者认为SANE是评估肩部疾病治疗效果的简便高效工具。

局限性

  • 作者认为需进一步研究以确认这些结果并比较其他身体部位和诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is an ever-increasing demand for widespread implementation of patient-reported outcomes. However, adoption is slow owing to limitations in clinical infrastructure and resources within busy orthopaedic practices. Prior studies showed the single alpha-numeric evaluation (SANE) score to correlate at a single point in time with the American Shoulder and Elbow Surgeons (ASES) score. However, no study has validated the SANE in terms of test-retest reliability, responsiveness, or clinical utility. PURPOSE: To validate SANE with the ASES across a sample of patients with common orthopaedic shoulder diagnoses. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 2. METHODS: Patients undergoing rotator cuff repair (n = 77), total shoulder replacement (n = 55), or physical therapy (n = 80) for signs and symptoms of subacromial impingement syndrome (n = 61) or adhesive capsulitis (n = 19) were administered the SANE and ASES at baseline and again at their 3-month follow-up from initial care or surgery (N = 212, mean ± SD age = 52.6 ± 1.2 years, n = 145 women). Interclass correlation coefficient (ICC2,1) and standard error of the measurement (SEm) were used to evaluate the test-retest reliability of the SANE and the validity between the SANE and ASES scores. Analysis of variance (treatment group × time) was used to evaluate the responsiveness to treatment, and a receiver operating characteristic curve was used to establish the minimal clinically important difference (MCID) for the SANE as compared with the ASES (α = .05). Floor and ceiling effects were evaluated as the percentage of patients who scored the highest or lowest score on each tool. RESULTS: The SANE demonstrated good pretreatment reliability (ICC2,1 = 0.84, SEM = 3.8), similar to the ASES (ICC2,1 = 0.82, SEM = 3.4). The SANE also showed good agreement with the ASES before and after treatment across all treatment groups (rotator cuff repair, ICC2,1 = 0.85, SEM = 3.4; total shoulder replacement, ICC2,1 = 0.72, SEM = 5.2; physical therapy: ICC2,1 = 0.82, SEM = 2.9). The SANE and ASES displayed similar responsiveness after treatment, with similar mean change and SD within each treatment group. The receiver operating characteristic curve revealed an area under the curve of 0.79 (SE, 0.62; P < .001) and a cutoff of 15% on the SANE, with a sensitivity of 85% to establish the MCID. Acceptable and similar floor and ceiling effects were observed for the ASES (4%) and SANE (9%). CONCLUSION: The study demonstrates that the SANE is valid for a range of common shoulder diagnoses to assess patient outcomes across operative and nonoperative treatment for shoulder complaints. The MCID of 15% is similar to that of the ASES (11%), suggesting that the SANE is a simple and efficient tool to assess treatment effects for shoulder disorders. Future studies are warranted to confirm these results and compare across other body parts and diagnoses.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Thigpen CA, Shanley E, Momaya AM, et al. Validity and Responsiveness of the Single Alpha-numeric Evaluation for Shoulder Patients. Am J Sports Med. 2018. PMID: 30419173. doi:10.1177/0363546518807924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。